Included 39 varieties China released the third batch of encouraged generic drug catalog

Mondo Health Updated on 2024-01-31

In order to implement the "Opinions on Reforming and Improving the Policy on the Protection and Use of Generic Drugs" issued by the General Office of the People's Republic of China and the "Notice on Printing and Distributing the Key Tasks for Deepening the Reform of the Medical and Health System in the Second Half of 2023" issued by 6 departments including the National Health Commission, the National Health Commission and the Ministry of Industry and Information Technology, the State Intellectual Property Office, the National Health Insurance Administration, the National Disease Control and Prevention Administration, the State Food and Drug Administration and other departments organized experts to conduct research on the upcoming expiration of domestic patents and clinical ** Drugs in short supply (insufficient competition) were selected and demonstrated, and the "Third Batch of Encouraged Generic Drugs List" was formulated.

It is understood that the "Third Batch of Encouraged Generic Drugs Catalogue" includes a total of 39 varieties of drugs, covering 12 aspects of anti-tumor drugs. It covers a wide range of disease fields, including 39 varieties, involving 75 specifications and 13 dosage forms, covering 12 aspects of antineoplastic drugs and immunomodulators, anti-infective drugs, nervous system drugs, radiodiagnostic agents, cardiovascular system drugs, etc. The third batch of catalogues fills the gap of clinical drugs in China, and many of the drugs included are overseas marketed and domestic unmarketed varieties, which are the world's first drugs in this field and have a new mechanism of action.

The third batch of encouraged generic drugs list.

Related Pages